{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:47:06Z","timestamp":1773247626015,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jns.2005.05.011","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T11:43:59Z","timestamp":1118835839000},"page":"75-81","source":"Crossref","is-referenced-by-count":50,"title":["A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy\/tropical spastic paraparesis"],"prefix":"10.1016","volume":"237","author":[{"given":"Toshio","family":"Matsuzaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Usuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Nose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Izumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiyoshi","family":"Arimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Osame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2005.05.011_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2005.05.011_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2005.05.011_bib3","first-page":"586","article-title":"HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings","volume":"4","author":"Nakagawa","year":"1998","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jns.2005.05.011_bib4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jns.2005.05.011_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ana.410240220","article-title":"Activated T-lymphocyte with polyclonal gammopathy in patients with human T-lymphotropic virus type I-associated myelopathy","volume":"24","author":"Mori","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2005.05.011_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0165-5728(89)90143-4","article-title":"Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-I-associated myelopathy (HAM\/TSP)","volume":"25","author":"Ijichi","year":"1989","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2005.05.011_bib7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.38.8.1302","article-title":"Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy","volume":"38","author":"Itoyama","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.05.011_bib8","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1002\/ana.410230744","article-title":"Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis","volume":"23","author":"Jacobson","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2005.05.011_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-5728(92)90006-7","article-title":"Cell surface phenotype of in vitro proliferating lymphocytes in HTLV-I-associated myelopathy (HAM\/TSP)","volume":"37","author":"Eiraku","year":"1992","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2005.05.011_bib10","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.177.6.1567","article-title":"High human T cell lymphotropic virus type 1 (HTLV-I)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I-associated neurological disease","volume":"117","author":"Elovaara","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2005.05.011_bib11","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1073\/pnas.95.13.7568","article-title":"Direct visualization of antigen-specific T cells: HTLV-I Tax11-19-specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM\/TSP patients","volume":"95","author":"Greten","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2005.05.011_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.10065","article-title":"Increased HTLV-I provirus load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM\/TSP","volume":"50","author":"Nagai","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2005.05.011_bib13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4049\/jimmunol.161.1.482","article-title":"Demonstration of human T lymphotropic virus type I (HTLV-I) Tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy\/tropical spastic paraparesis patients by intracellular cytokine detection","volume":"161","author":"Kubota","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2005.05.011_bib14","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","article-title":"HLA alleles determine human T-lymphotropic virus-I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy","volume":"96","author":"Jeffery","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2005.05.011_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.410210203","article-title":"Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells","volume":"21","author":"Osame","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2005.05.011_bib16","first-page":"271","article-title":"HTLV-I-associated myelopathy (HAM). Treatment trials, retrospective survey, and clinical and laboratory findings","volume":"3","author":"Osame","year":"1990","journal-title":"Hematol Rev"},{"key":"10.1016\/j.jns.2005.05.011_bib17","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(88)90525-9","article-title":"Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy","volume":"2","author":"Matsuo","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2005.05.011_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2169\/internalmedicine1962.29.362","article-title":"The efficacy of interferon-alpha treatment in human T-lymphotropic virus type-I-associated myelopathy","volume":"29","author":"Nakamura","year":"1990","journal-title":"Jpn J Med"},{"key":"10.1016\/j.jns.2005.05.011_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0404.1992.tb08059.x","article-title":"Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy","volume":"86","author":"Kuroda","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2005.05.011_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-510X(96)05319-1","article-title":"Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy\/tropical spastic paraparesis: a combined clinical, virological and immunological study","volume":"147","author":"Yamasaki","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2005.05.011_bib21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","article-title":"Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial","volume":"46","author":"Izumo","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.05.011_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1086\/380101","article-title":"Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"189","author":"Saito","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jns.2005.05.011_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-1605(98)00046-4","article-title":"Immunomodulation by treatment with Lactobacillus casei strain Shirota","volume":"41","author":"Matsuzaki","year":"1998","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.jns.2005.05.011_bib24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/IAI.48.2.480-485.1985","article-title":"Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice","volume":"48","author":"Miake","year":"1985","journal-title":"Infect Immun"},{"key":"10.1016\/j.jns.2005.05.011_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1348-0421.1984.tb00672.x","article-title":"Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens","volume":"27","author":"Kato","year":"1984","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jns.2005.05.011_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00199932","article-title":"Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice","volume":"26","author":"Kato","year":"1988","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jns.2005.05.011_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s004300050112","article-title":"Inhibitory effect of oral administration of Lactobacillus casei on 3-methylchoranthrene-induced carcinogenesis in mice","volume":"188","author":"Takagi","year":"1999","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.jns.2005.05.011_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0024-3205(98)00315-4","article-title":"Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA\/1 mice","volume":"63","author":"Kato","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.jns.2005.05.011_bib29","first-page":"91","article-title":"Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei","volume":"17","author":"Nomoto","year":"1985","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/j.jns.2005.05.011_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1348-0421.1986.tb00926.x","article-title":"Protection of mice against herpes simplex virus infection by a Lactobacillus casei preparation (LC9018) in combination with inactivated viral antigen","volume":"30","author":"Watanabe","year":"1986","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jns.2005.05.011_bib31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/CDLI.11.4.675-679.2004","article-title":"Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota","volume":"11","author":"Yasui","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jns.2005.05.011_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-510X(91)90125-Q","article-title":"Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"105","author":"Fujihara","year":"1991","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.jns.2005.05.011_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-5728(91)90056-D","article-title":"Natural killer (NK) cells in HTLV-I-associated myelopathy\/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-I seropositive individuals","volume":"33","author":"Yu","year":"1991","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2005.05.011_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood-2002-09-2855","article-title":"Low frequency of CD94\/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy\/ tropical spastic paraparesis, but not in asymptomatic carriers","volume":"102","author":"Saito","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jns.2005.05.011_bib35","series-title":"Human Retrovirology","first-page":"191","article-title":"Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP","author":"Osame","year":"1990"},{"key":"10.1016\/j.jns.2005.05.011_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified Ashworth scale of muscle spasticity","volume":"67","author":"Bohannon","year":"1987","journal-title":"Phys Ther"},{"key":"10.1016\/j.jns.2005.05.011_bib37","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.186.9.1407","article-title":"Phenotypic and functional separation of memory and effector human CD8+ T cells","volume":"186","author":"Hamann","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2005.05.011_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000282409","article-title":"Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer, BLP Study Group","volume":"49","author":"Aso","year":"1992","journal-title":"Urol Int"},{"key":"10.1016\/j.jns.2005.05.011_bib39","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1271\/bbb.64.2706","article-title":"Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects","volume":"64","author":"Nagao","year":"2000","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.jns.2005.05.011_bib40","first-page":"5","article-title":"Phagocytosis of the lactic acid bacteria by M cells in the rabbit Payer's patches","volume":"24","author":"Takahashi","year":"1991","journal-title":"J Clin Electron Microsc"},{"key":"10.1016\/j.jns.2005.05.011_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S095279150200002X","article-title":"Natural killer cells and viral infections","volume":"15","author":"French","year":"2003","journal-title":"Curr Opin Immunol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X05001954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X05001954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:32:41Z","timestamp":1683113561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X05001954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0022510X05001954"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2005.05.011","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}